Back to search
FDAFDA · Food and drugs·Recall number Z-1414-2021

cobas Liat Analyzer: respiratory virus panel nucleic acid assay system Catalog Number: 07341920190

Published April 21, 2021 · Recall initiated: March 25, 2021

Summary

FDA records medical device Class II recall Z-1414-2021, published April 21, 2021 and initiated March 25, 2021. Recalling firm: Roche Molecular Systems, Inc.; Status: Ongoing; Reported quantity: US: 5,430 units ; OUS 1528 units; Lot: All serial ID numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Invalid or false positive results for one or more targets (SARS-CoV-2/Influenza A/Influenza B) using the cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization on the cobas Liat analyzer, showed abnormal PCR growth curves

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Molecular Systems, Inc.
Distributor
Nationwide WorldWide
Lot
All serial ID numbers
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was cobas Liat Analyzer: respiratory virus panel nucleic acid assay system Catalog Number: 07341920190 recalled?

Yes. FDA published recall Z-1414-2021 on April 21, 2021. Reported hazard: Invalid or false positive results for one or more targets (SARS-CoV-2/Influenza A/Influenza B) using the cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization on the cobas Liat analyzer, showed abnormal PCR growth curves

What should I do if I have this product?

Voluntary: Firm initiated · Letter